Active Clinical Trials

October 19, 2020
TMIST accrual bar graph
October 19, 2020
Categories

TMIST Breast Cancer Screening Trial Rebounds from COVID-19 Shutdown of Cancer Screenings

October accrual is on pace to be the highest month on record. Since July 1, TMIST has enrolled more patients than all other National Cancer Institute clinical trials combined. An unheard-of number (nearly 20%) are Black and African American women. Drs. Etta Pisano and Mitch Schnall provide the latest status of the trial and discuss its continuing relevance
Do you like it?
0 Read more
October 19, 2020
Blood pressure machine
October 19, 2020
Categories

Now Enrolling: EAQ191 / CARISMA for management of hypertension in patients with metastatic renal cell or thyroid cancer on anti-angiogenic tyrosine kinase inhibitors

This phase II study, led by Dr. Bonnie Ky, aims to generate the necessary data to inform a phase III randomized controlled trial with the potential to make a significant public health impact
Do you like it?
0 Read more
September 14, 2020
Ingrid Mayer, MD
September 14, 2020
Categories

Trial Spotlight: Ingrid Mayer on Study EA1131 for Triple-Negative Breast Cancer, Including Men

This is the only study that is currently designed to test the ability to improve long-term outcomes by refining early-setting triple-negative breast cancer chemotherapy without exposing ALL patients to more toxicity preoperatively
Do you like it?
0 Read more
April 15, 2020
Patient in office
April 15, 2020
Categories

Now Enrolling: EA1181 Decreasing Chemotherapy in HER2 Positive Breast Cancer

For patients who have a pathologic complete response (pCR) after 12 weeks of pre-operative THP (single agent taxane plus trastuzumab and pertuzumab), is it safe to omit additional therapy after surgery?
Do you like it?
0 Read more
12345678